-
Monkeypox Vaccine and Treatment Market to Reach USD 225.12 Mn by 2032, Driven by Rising Outbreaks and Antiviral Demand
22 Oct 2025 04:08 GMT
… (US)
Moderna (US)
Vaxart (US)
Sanofi Pasteur (US)
Instituto Nacional de Salud …
-
Second Circuit – Sherman Act: Mosaic Health Inc. v. Sanofi-Aventis U.S. LLC
30 Sep 2025 12:14 GMT
… complaint
Mosaic Health Inc. v. Sanofi-Aventis U.S. LLC
24-598 …
-
Anxiety Disorders and Depression Treatment Market Growth and Company Analysis Report 2025-2033 Featuring Abbvie, BMS, Eli Lily & Co, GSK, H. Lundbeck, J&J, Merck, Pfizer, Sanofi-Aventis, Axsome – ResearchAndMarkets.com
12 Sep 2025 17:13 GMT
… & Co. Inc
Pfizer Inc
Sanofi-Aventis
Axsome Therapeutics
Key Attributes:
Report …
-
Clover Appoints Nicholas Jackson, Ph.D., as President of Global R&D and Alliances
19 Oct 2025 23:35 GMT
… Head of Global Research for Sanofi Pasteur, responsible for leading vaccine research …
-
IPV Vaccines Market Set to Expand at CAGR of 8.7% Through 2032 | Sanofi Pasteur, GlaxoSmithKline plc
12 Jun 2025 10:41 GMT
IPV Vaccines Market Research Report Information By Vaccine Brand, By Distribution Channel, And By Region
MI, UNITED STATES, June 12, 2025 /EINPresswire.com/ -- IPV Vaccines Insights
The global IPV vaccines market is estimated to be valued at …
-
Adult Vaccine Market Forecast Report and Company Analysis 2025-2033 Featuring GlaxoSmithKline, AstraZeneca, Sanofi Pasteur, Pfizer, BMS, CSL, Novartis, Eli Lily - ResearchAndMarkets.com
19 May 2025 15:37 GMT
… , Revenue
GlaxoSmithKline, plc.
AstraZeneca plc
Sanofi Pasteur
Pfizer, Inc.
CSL Limited
Bristol …
-
<![CDATA[Tarlatamab Plus Chemo/IO Regimens Are Safe, Elicit Responses in ES-SCLC]]>
18 Oct 2025 17:13 GMT
Tarlatamab plus frontline chemoimmunotherapy and PD-L1 maintenance therapy demonstrated both encouraging safety and clinical outcomes in patients with extensive-stage (ES) small cell lung cancer (SCLC), according to cohort results of the phase 1b DeLLphi- …
-
Shenzhen's biopharma firm signs deal with global leader in cell therapy
17 Oct 2025 14:24 GMT
… has attracted foreign companies like Sanofi Pasteur and nurtured leading pharmaceutical companies …
-
New era in protecting all infants against RSV infection from the earliest days of life with long-acting monoclonal antibody Nirsevimab
17 Oct 2025 05:03 GMT
… Research Institute with sponsorship from Sanofi Aventis Vietnam Co., Ltd., a subsidiary …
-
United States Influenza Vaccines Market Research 2025 Featuring Sanofi Pasteur, GSK, Seqirus, Astrazeneca - Size, Shares Data, Latest Trends, Insights, Growth Potential, CAGR Forecasts To 2033
16 Jan 2025 10:16 GMT
… pharmaceutical companies such as GlaxoSmithKline, Sanofi Pasteur, AstraZeneca and Seqirus, which together … Emerging Player's Profiles Sanofi Pasteur GlaxoSmithKline (GSK) Seqirus (CSL … Key Company Profiles
18.1 Sanofi Pasteur
18.1.1 Business Overview …
About
© 1995-2025